The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Fydrane 0.2 mg/ml + 3.1 mg/ml + 10 mg/ml, solution for injection

Laboratoires TheaPA1107/012/001

Main Information

Trade NameFydrane 0.2 mg/ml + 3.1 mg/ml + 10 mg/ml, solution for injection
Active SubstancesTropicamide
Phenylephrine hydrochloride
Lidocaine Hydrochloride Monohydrate
Dosage FormSolution for injection
Licence HolderLaboratoires Thea
Licence NumberPA1107/012/001

Group Information

ATC CodeS01FA Anticholinergics
S01FA56 tropicamide, combinations


License statusAuthorised
Licence Issued28/08/2015
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back